FDA makes changes for device and emergency use authorizations

07/30/2013 | Clinica

The FDA will provide a single submission number for investigational device exemptions and emergency use authorizations beginning Aug. 18, which will allow the agency to track multiple studies and milestones more efficiently and will streamline the entire process. Subsequent submissions to an IDE or EUA will be assigned to the appropriate study and will be classified as supplements, reports or amendments. Under the new system, companies should ensure that they include only one submission reason per IDE submission

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC